Quick navigation menu :

Go to the breadcrumb
Go to the language menu
Go to the tools menu
Go to the search form
Go to the primary menu
Go to the content
Go to the slots area
Go to the footer

Menu outils :

Primary navigation :

International presence

Quick links

Publications

Diary

Financial calendar

Headline

Second Quarter 2009 Results

July 29, 2009: Audio webcast of the conference call

Access all information

Diversification and external growth

Innovating in R&D, strengthening business activities

To find out more about sanofi-aventis’ activities

Lantus® (insulin glargine)

Information space on appropriate product use

Access information space

Sanofi-aventis wins a prize for “Breakthrough innovation”

To find out more

Disability and internet: Sanofi-aventis’ commitments

To find out more

Latest publications

All press releases

September 21, 2009

Sanofi Pasteur Receives Additional Order from U.S. Government to Produce Influenza A (H1N1) Vaccine

September 21, 2009

Sanofi-aventis receives renewed recognition as a leader in sustainability

September 18, 2009

Sanofi-aventis completes Acquisition of Merck's Interest in Merial

September 16, 2009

Sanofi-aventis Receives Complete Response Letter from the FDA for Eplivanserin (Ciltyri®) Submission

Sanofi Pasteur website

Euronext Paris (SAN)

Quote: €51.32. Level change: +0.98%
Last update: Sept 22, 2009 05.13 PM (CET)

NYSE (SNY)

Quote: $37.77. Level change: +1.50%
Last update: Sept 22, 2009 10.58 AM (EST)

Working for sustainability

Sustainability website